Name of bioresource/bank
NeuroBioTec Biobank – Hospices Civils de Lyon
Name of Principal Investigator
Address of institution where award is held
|Institution||Hopital Neurologique, Hospices Civils de Lyon|
|Street Address||59, Boulevard Pinel|
Contact email (e.g. manager or coordinator)
Hospices Civils de Lyon
Q1 What conditions does your resource cover?
Alzheimer’s disease and other dementias Parkinson’s disease Neurodegenerative disease in general
Q2a What DNA collection does your resources hold?
Q2b What cell lines does your resource hold?
Q2c What tissue (including post-mortem tissue) does your resource hold?
Q3 Are human tissues/samples/DNA from
Living donors:blood Living donors: blood derivatives Living donors: DNA Living donors: peripheral nerve biopsy Living donors: skeletal muscle biopsy Living donors: cerebro-spinal fluid
Q4 Are tissues/samples/DNA from
Healthy individuals/control donors Patients
Q5 Can samples be linked to clinical (phenotypic) information and if so, is this information:
Routinely collected as medical records In a specific study-associated dataset
Q6 In what form are samples supplied?
Primary Samples: Stabilised samples (frozen or fixed) Secondary samples: plasma Secondary samples: DNA
Q7 Are biomarkers/analytes/biological characteristics already measured and the information available for your samples?
In a few samples
Q8 What is the status of your tissue/sample/DNA collection?
Collection completed and available for use
Q9 What are the rules and procedures for access?
Access independent of collaboration with PI Access Committee mechanism International access Access to industry Resource has own ethics approval so usually no need for separate external ethics approval